Sign in Subscribe
Pharmaceutical industry

Global Depression Drugs Market to Grow at 5.25% CAGR from 2014-2019

Strategic Insights

— 1 min read

Research and Markets has forecasted that the global depression drugs market will grow at a compound annual growth rate (CAGR) of 5.25% over the period 2014-2019. The growth of the market is expected to be driven by increasing public awareness about depression, which will lead to increased acceptability of various drugs. Key non-profit organizations such as the Anxiety and Depression Association of America, Mental Health America, and the Depression and Bipolar Support Alliance are involved in spreading awareness of depression and its implications.

Key Takeaways:

  • The global depression drugs market is expected to grow at a CAGR of 5.25% from 2014-2019, driven by increasing public awareness about depression.
  • Key vendors in the market include Actavis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Pfizer, among others.
  • The market is expected to be influenced by non-profit organizations such as the Anxiety and Depression Association of America, Mental Health America, and the Depression and Bipolar Support Alliance, which are involved in spreading awareness of depression and its implications.
  • According to the World Health Organization, depression is one of the most disabling illnesses worldwide.
  • In 2012, it was estimated that more than 18 million people suffered from depression in the US, affecting about 25% of women and 10% of men.
  • The Centers for Disease Control and Prevention (CDC) estimates that about one in every 10 individuals in the US suffers from depression.

Statistics:

  • CAGR of 5.25% expected for the global depression drugs market from 2014-2019.
  • Over 18 million people suffered from depression in the US in 2012, affecting about 25% of women and 10% of men.
  • About one in every 10 individuals in the US suffers from depression, according to the CDC.
  • Depression is described as one of the most disabling illnesses worldwide by the World Health Organization.

Sources:

  • "Global Depression Drugs Market 2015-2019" report by Research and Markets.
  • "Global Depression Drugs Market 2015-2019" press release by Research and Markets (June 24, 2015).
  • World Health Organization (WHO).
  • Centers for Disease Control and Prevention (CDC).
  • Anxiety and Depression Association of America.
  • Mental Health America.
  • Depression and Bipolar Support Alliance.

Read more